---
title: "Eyebright Medical released its 2024 annual performance, with a net profit attributable to the parent company of 388 million yuan, a year-on-year increase of 27.77%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236991369.md"
description: "According to the Zhitong Finance APP, Eyebright Medical released its 2024 annual report, stating that the company's operating revenue for 2024 is CNY 1.41 billion, a year-on-year increase of 48.24%; the net profit attributable to shareholders of the listed company is CNY 388 million, a year-on-year increase of 27.77%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses is CNY 390 million, a year-on-year increase of 35.08%; the basic earnings per share is CNY 2.05"
datetime: "2025-04-22T13:43:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236991369.md)
  - [en](https://longbridge.com/en/news/236991369.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236991369.md)
generator: "portal-rs"
---

# Eyebright Medical released its 2024 annual performance, with a net profit attributable to the parent company of 388 million yuan, a year-on-year increase of 27.77%

According to the Zhitong Finance APP, Eyebright Medical (688050.SH) released its annual report for 2024, reporting an operating income of 1.41 billion yuan for the year 2024, a year-on-year increase of 48.24%; a net profit attributable to shareholders of the listed company of 388 million yuan, a year-on-year increase of 27.77%; a net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses of 390 million yuan, a year-on-year increase of 35.08%; and basic earnings per share of 2.05 yuan/share

### Related Stocks

- [688050.CN](https://longbridge.com/en/quote/688050.CN.md)

## Related News & Research

- [16:48 ETGI MAP Test Launches Cyclospora Guidance Service for Customers With a Detected Test Result](https://longbridge.com/en/news/296535077.md)
- [Flexdeal chair Alberto Amaral buys EUR 150,000 in shares](https://longbridge.com/en/news/296250174.md)
- [Trump Picks White House Health Adviser Heidi Overton to Lead FDA After Marty Makary’s Exit](https://longbridge.com/en/news/296315647.md)
- [04:31 ETGovee Collaborates with Interior Designers to Showcase Smart Lighting as a New Element of Home Design](https://longbridge.com/en/news/296458067.md)
- [Chromaviso circadian lighting cuts sick leave up to 21%, InnovationsFonden-backed study shows](https://longbridge.com/en/news/296603687.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**